Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-08-11 02:02 UTC

BIOMED PULSE

August 11, 2026 | Daily Briefing on Longevity, Viruses & New Cures

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in DRC and Uganda has now surpassed 2,100 confirmed cases and 828 deaths as of July 15, making it the dominant global health crisis of 2026. [1] The overall mood is high-alert: multiple simultaneous outbreaks — Ebola, Cyclospora, Salmonella, West Nile — are straining public health systems even as promising longevity and drug approval signals emerge. [2] [3]

🦠 OUTBREAKS & VIRUSES

EBOLA (BUNDIBUGYO VIRUS) — DRC AND UGANDA

  • As of July 15, 2026, WHO confirmed 2,124 cumulative confirmed cases and 828 deaths from Bundibugyo virus disease (BVD) in the DRC, with cross-border transmission ongoing into Uganda. [1]
  • The outbreak originated in Mongbwalu Health Zone, Ituri Province, DRC, after WHO was alerted on May 5, 2026, to a high-mortality illness cluster including deaths among health workers. [4]
  • The August 1 WHO update describes the outbreak as intensifying with sustained transmission that has spread beyond Ituri Province over the past two months. [2]
  • CDC mobilized an international Ebola response on May 17, 2026, and enhanced airport screening was activated at Washington-Dulles International Airport on May 21, subsequently expanding to Atlanta. [5] [6]

CYCLOSPORA — TACO BELL / ICEBERG LETTUCE, MULTISTATE

  • Shredded iceberg lettuce served at Taco Bell locations was confirmed as the source of Cyclospora infections spanning five states, with 1,644 people reported sick as of July 17, 2026. [3]
  • The outbreak expanded to four additional states as of July 24, 2026, making it one of the largest Cyclospora outbreaks linked to a single food-service chain in recent CDC history. [7]
  • A CDC Cyclosporiasis response transcript was issued July 14, 2026, indicating active federal coordination with state partners. [8]

WEST NILE VIRUS — UNITED STATES

  • CDC reported an early West Nile season with record case numbers as of July 1, 2026, urging Americans to use mosquito repellent throughout the July 4th holiday weekend and beyond. [9]

SALMONELLA — JALAPEÑOS, MULTISTATE

  • CDC posted a food safety alert on August 5, 2026, warning of a multistate Salmonella outbreak linked to jalapeños. [10]

HANTAVIRUS — M/V HONDIUS CRUISE SHIP, MULTI-COUNTRY

  • The Andes hantavirus (ANDV) outbreak linked to the M/V Hondius cruise ship continued through at least July 2, 2026, marking the fifth WHO Disease Outbreak News posting on this event, which began with WHO notification on May 2, 2026.
  • As of May 28 (DON 4), additional confirmed cases had accumulated beyond the original two lab-confirmed and five suspected cases first reported on May 4, with severe respiratory illness the defining clinical picture.

NIPAH VIRUS — INDIA (KERALA)

  • On June 11, 2026, Kerala State Health Department confirmed one lab-confirmed Nipah virus (NiV) case in Kozhikode district: an adult male with symptom onset May 30, hospitalized June 10, presenting with neurological symptoms.

MPOX — RECOMBINANT CLADE Ib/IIb STRAIN

  • WHO reported in February 2026 two cases of a recombinant mpox strain combining genomic elements of clade Ib and clade IIb monkeypox virus (MPXV), a naturally occurring but surveillance-relevant event requiring close monitoring.

YELLOW FEVER — GLOBAL

  • WHO reported that from January 1 to May 26, 2026, six countries recorded 79 human yellow fever infections, with transmission persisting into 2026 following an elevated 2025 season in the Americas.

MEASLES — BANGLADESH

  • On April 4, 2026, Bangladesh notified WHO of a nationwide measles surge affecting 58 of 64 districts across all eight divisions, with 19,161 suspected cases and 2,897 laboratory-confirmed cases reported.

E. COLI — FROZEN BLUEBERRIES

  • CDC issued a food safety alert on July 7, 2026, warning of an E. coli outbreak linked to frozen blueberries, with a product recall in effect.

🧬 LONGEVITY & AGING

SENESCENCE AND BONE LOSS

  • A Europe PMC study (Wang Y et al., Regen Ther, July 2026) found that punicalagin — a polyphenol from pomegranate — alleviates senile osteoporosis by inhibiting the senescence of bone mesenchymal stem cells via the NRF2/HO-1 antioxidant pathway, pointing to a diet-linked mechanism for slowing age-related bone deterioration.

COLLAGEN XVII AND SKIN PHOTOAGING

  • Wang X et al. (Ann Med, July 2026) demonstrated that recombinant human collagen XVII protects epidermal stem cells from blue-light-induced photoaging by downregulating the Notch signaling pathway, a finding relevant to both cosmetic and regenerative medicine.

METFORMIN AND PHYSICAL FUNCTION IN OLDER ADULTS WITH OBESITY — DEMFOS TRIAL

  • The DEMFOS randomized controlled trial (Nava MLD et al., Lancet Healthy Longev) tested metformin added to lifestyle intervention for improving physical function in older adults with obesity, with a commentary noting that expectations for metformin's benefits in this context may need recalibration.
  • An accompanying Lancet Healthy Longev commentary by Witham MD and McDonald C cautions against inflated expectations for adjunctive metformin in treating obesity and frailty in older people.

POSITIVE LIFE ORIENTATION AND BLOOD PRESSURE

  • A Finnish two-generational cohort study (Lääti A et al., Blood Press, August 2026) found associations between positive life orientation and lower blood pressure in older adults, linking psychological disposition to a measurable cardiovascular aging marker.

TELOMERE REPAIR AND CANCER CELL SENESCENCE

  • Salmina K et al. (Nucleus, July 2026) investigated repair and misrepair of telomeric DNA in doxorubicin-treated cancer cells, highlighting dynamic interactions with PML nuclear bodies and lamin B1 — structures central to how cells manage genomic aging stress.

LIVER METABOLISM AND AMPK ACTIVATION

  • Zhu J et al. (Bioact Mater, July 2026) showed that targeting ROAM1 with UDP-GlcNAc nanosheets selectively activates lysosomal AMPK — an enzyme linked to cellular energy sensing and longevity — to resolve metabolic dysfunction-associated steatotic liver disease (MASLD) in preclinical models.

DIET AND EPIGENETIC AGING IN DOGS (PILOT)

  • Chen A et al. (Vet Rec Open, August 2026) reported in a pilot study that feeding dogs a minimally processed, human-grade diet altered canine epigenetic aging clocks, raising translational questions about diet-epigenome interactions relevant to mammalian longevity research broadly.

p16-INK4A SENESCENCE MARKER VALIDATION

  • Pipella J and Thompson PJ (Islets, July 2026) stressed the critical importance of antibody validation when detecting the cell-cycle regulatory protein p16-INK4A by immunohistochemistry in pancreatic tissue — p16-INK4A being a front-line biomarker of cellular senescence.

💊 NEW CURES & APPROVALS

ORFORGLIPRON (FOUNDAYO) — ELI LILLY AND CO

  • Eli Lilly's FOUNDAYO (orforglipron calcium), an oral GLP-1 receptor agonist, received a supplemental FDA approval action (SUPPL AP) under NDA220934, broadening options for metabolic disease management beyond injectable GLP-1 therapies.

OVEPOREXTON (ORZEYFUL) — TAKEDA PHARMACEUTICALS USA

  • Takeda's ORZEYFUL (oveporexton) received an original FDA approval (ORIG AP) under NDA220860, representing a new orexin receptor agonist class entry for indications related to wakefulness and sleep-wake disorders.

NINTEDANIB ESYLATE — MACLEODS PHARMACEUTICALS LTD

  • Macleods Pharma received an original ANDA approval (ORIG AP, ANDA219926) for generic nintedanib esylate, an antifibrotic tyrosine kinase inhibitor used in idiopathic pulmonary fibrosis and systemic sclerosis-associated ILD, expanding affordable access.

SACUBITRIL/VALSARTAN — UMEDICA

  • Umedica received an original ANDA approval (ORIG AP, ANDA219946) for generic sacubitril/valsartan, the angiotensin receptor-neprilysin inhibitor (ARNI) combination used in heart failure with reduced ejection fraction.

ABALOPARATIDE (TYMLOS) — RADIUS HEALTH

  • Radius Health's TYMLOS (abaloparatide), a PTHrP analog for postmenopausal osteoporosis, received a supplemental FDA approval (SUPPL AP, NDA208743), potentially covering a new indication or formulation update relevant to bone aging.

TERIPARATIDE (FORTEO) — LILLY; AND (ALMAJECT) — ALMAJECT

  • Both Lilly's FORTEO (NDA021318) and Almaject's biosimilar teriparatide (NDA218771) received supplemental approvals (SUPPL AP), supporting continued access to PTH-based anabolic osteoporosis therapy.

INDOCYANINE GREEN — ZYDUS LIFESCIENCES

  • Zydus Lifesciences received an original ANDA approval (ORIG AP, ANDA219139) for indocyanine green, used in cardiac output measurement, hepatic function assessment, and intraoperative imaging.

🧪 CLINICAL TRIALS

EVEROLIMUS AGING STUDY — mTORC1 INHIBITION IN HUMANS (NCT05835999)

  • This trial is evaluating whether 24 weeks of daily (0.5 mg/day) or weekly (5 mg/week) everolimus — an mTORC1 inhibitor — can safely improve physiological and molecular hallmarks of aging in insulin-resistant or prediabetic adults aged 55-80.
  • mTORC1 inhibition is one of the most reproducible longevity pathways in model organisms; this trial is testing direct translation into humans at low, potentially tolerable doses.

SINGER STUDY — MULTIDOMAIN AGING INTERVENTION, SINGAPORE (NCT05007353)

  • The Singapore Geriatric Intervention Study to Reduce Cognitive Decline and Physical Frailty (SINGER) is testing a multidomain approach — physical activity, nutrition, cognitive training, social engagement, and vascular risk management — modeled on the Finnish FINGER trial, in older Singaporean adults at elevated cognitive decline risk.

PACRITINIB FOR MDS/MPN — KINASE INHIBITION IN BLOOD AGING DISORDERS (NCT06303193)

  • A trial of pacritinib, a kinase inhibitor targeting CSF1R, IRAK1, JAK2, and FLT3, is enrolling adults and pediatric participants 12 years and older with myelodysplastic syndromes (MDS) or MDS/myeloproliferative neoplasms, conditions with strong age-related incidence that can progress to AML.

B7-H3 CAR-T FOR SMALL CELL LUNG CANCER (NCT07509034)

  • A trial of autologous B7-H3-targeting chimeric antigen receptor T cells is open for previously treated extensive-stage small cell lung cancer and extrapulmonary neuroendocrine cancer, diseases with sharply age-skewed incidence and very poor prognosis.

AML MYELOMATCH TREATMENT TRIAL — CYTARABINE VS. EXPERIMENTAL REGIMENS (NCT05554406)

  • This Phase II MyeloMATCH trial is comparing standard cytarabine/daunorubicin against experimental regimens including liposomal cytarabine/daunorubicin in newly diagnosed high-risk acute myeloid leukemia, an age-associated malignancy.

ESK-001 FOR MODERATE-TO-SEVERE PLAQUE PSORIASIS (NCT06586112)

  • A trial is evaluating the efficacy and safety of ESK-001, targeting an undisclosed mechanism, in adults with moderate-to-severe plaque psoriasis, an immune-mediated inflammatory disease with significant quality-of-life impact in aging populations.

📢 PUBLIC HEALTH

HHS RESPONSE TO CDC HEADQUARTERS ATTACK

  • HHS Secretary Robert F. Kennedy Jr. visited CDC headquarters on August 11, 2026, following a tragic gunfire attack at the facility; the statement does not provide casualty details.

DRUG-RESISTANT BACTERIA ON THE RISE

  • A September 2025 CDC report documented a dramatic increase in dangerous drug-resistant bacteria, underscoring the ongoing antimicrobial resistance threat to health systems.

CONGENITAL SYPHILIS — 12TH CONSECUTIVE ANNUAL INCREASE

  • CDC data released September 2025 showed U.S. newborn syphilis cases rose for the 12th consecutive year in 2024, marking a prolonged and worsening trend in a preventable vertical transmission infection.

TICK BITE ER VISITS ABOVE SEASONAL NORM

  • CDC reported in April 2026 that weekly emergency room visits for tick bites were running higher than usual, activating public health resources ahead of peak tick season.

U.S. WITHDRAWAL FROM WHO COMPLETED

  • The United States formally completed its WHO withdrawal on January 22, 2026; WHO called the exit a decision that "makes both the United States and the world less safe."

TIMOR-LESTE CERTIFIED MALARIA-FREE BY WHO

  • WHO certified Timor-Leste as malaria-free on July 23, 2025, following a nationwide effort begun shortly after the country's independence in 2002, providing a model for elimination in resource-limited settings.

NOTE: This briefing is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  2. Ebola disease caused by Bundibugyo virus - Democratic Republic… — WHO Disease Outbreak News
  3. Shredded iceberg lettuce served at Taco Bell locations is sour… — CDC Newsroom
  4. Ebola disease caused by Bundibugyo virus, Democratic Republic … — WHO Disease Outbreak News
  5. Enhanced Ebola Airport Screening Begins at Washington-Dulles I… — CDC Newsroom
  6. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  7. Cyclospora outbreak linked to iceberg lettuce expanded to four… — CDC Newsroom
  8. Transcript - Update on CDC's Cyclosporiasis Response - 7/14/26 — CDC Newsroom
  9. CDC Encourages Americans to Stay Mosquito Bite-Free during Ame… — CDC Newsroom
  10. CDC warns of <em>Salmonella</em> outbreak linked to jalapeños — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260811-02-v52 · 2026-08-11 02:02 UTC · pulse.uzylab.com

Read next